GlassScriptPhysician profile
Charles Woo
NPI 1811961543
$9,803.99
in general payments reported to CMS, 2019-2025
66 companies · $2,495 in 2025
The $2,495 reported for 2025 was more than what 91% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $868 · 2020: $617 · 2021: $1,258 · 2022: $1,552 · 2023: $1,633 · 2024: $1,381 · 2025: $2,495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,216 · Travel and Lodging: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,216.14 |
| Travel and Lodging | $293.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,113.07 | 2019-2025 | |
| Janssen Biotech, INC. | $915.42 | 2019-2025 | Tecvayli, Darzalex, Talvey |
| Astrazeneca Pharmaceuticals LP | $672.30 | 2019-2025 | Enhertu, Imfinzi, Lynparza |
| Abbott Laboratories | $427.96 | 2023-2025 | Proclaim |
| Pfizer INC. | $378.68 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $361.41 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Regeneron Healthcare Solutions, INC. | $350.02 | 2019-2025 | Libtayo |
| Takeda Pharmaceuticals U.S.A., INC. | $330.15 | 2019-2025 | Iclusig, Alunbrig, Ninlaro |
| Daiichi Sankyo INC. | $311.52 | 2020-2025 | Enhertu, Datroway, Injectafer |
| Incyte Corporation | $286.78 | 2019-2025 | Monjuvi, Jakafi, Pemazyre |
| Abbvie INC. | $286.41 | 2019-2025 | Lupron Depot, Venclexta |
| Pharmacyclics LLC, An Abbvie Company | $281.86 | 2019-2023 | Imbruvica, Epkinly |
| Puma Biotechnology, INC. | $279.48 | 2019-2024 | |
| Amgen INC. | $276.33 | 2020-2023 | Lumakras, Kyprolis, Blincyto |
| Bayer Healthcare Pharmaceuticals INC. | $217.51 | 2019-2025 |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $199.52 | 2021-2025 | Zoladex |
| Ipsen Biopharmaceuticals, INC | $192.76 | 2019-2024 | Onivyde |
| Genzyme Corporation | $191.21 | 2020-2025 | |
| Seagen INC. | $178.38 | 2019-2023 | Padcev, Adcetris |
| Novocure INC. | $170.93 | 2019-2022 | |
| Eisai INC. | $164.21 | 2021-2025 | |
| Genentech USA, INC. | $160.48 | 2024-2025 | Polivy, Alecensa, Itovebi |
| Lilly USA, LLC | $143.07 | 2021-2025 | Jaypirca, Retevmo, Verzenio |
| Glaxosmithkline, LLC. | $121.40 | 2020-2025 | Zejula, Ojjaara, Blenrep |
| Blueprint Medicines Corporation | $114.15 | 2020-2025 | Ayvakit |
| Jazz Pharmaceuticals INC. | $112.01 | 2022-2024 | Zepzelca |
| Aveo Pharmaceuticals, INC. | $105.04 | 2022-2025 | Fotivda |
| E.R. Squibb & Sons, L.L.C. | $104.56 | 2020-2023 | Opdivo |
| Rigel Pharmaceuticals, INC. | $84.19 | 2020-2025 | Rezlidhia, Gavreto, Tavalisse |
| Adc Therapeutics America, INC. | $83.74 | 2025 | |
| Stemline Therapeutics INC. | $80.36 | 2023-2025 | Orserdu |
| Astellas Pharma US INC | $77.30 | 2019-2022 | |
| Emd Serono, INC. | $73.77 | 2021-2023 | Bavencio |
| Sobi, INC | $72.12 | 2022-2025 | |
| Legend Biotech USA INC. | $64.36 | 2025 | Carvykti |
| Geron Corporation | $61.54 | 2025 | Rytelo |
| G1 Therapeutics, INC. | $52.85 | 2022-2023 | Cosela |
| Celgene Corporation | $48.23 | 2019 | |
| Exelixis INC. | $47.72 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.24 | 2022-2024 | Gilotrif |
| Cti Biopharma Corp. | $38.73 | 2023 | Vonjo |
| Epizyme, INC. | $38.62 | 2020-2022 | |
| Clovis Oncology, INC. | $35.53 | 2021 | |
| Morphosys, US INC. | $34.57 | 2022 | |
| Beigene USA, INC. | $30.15 | 2023-2024 | Brukinsa |
| Genmab U.S., INC. | $27.48 | 2023 | Tivdak |
| Karyopharm Therapeutics INC. | $27.11 | 2024-2025 | Xpovio |
| Pharmaessentia USA Corporation | $26.10 | 2025 | Besremi |
| Deciphera Pharmaceuticals INC. | $22.40 | 2023 | Qinlock |
| Dova Pharmaceuticals | $21.47 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $19.85 | 2025 | Sancuso |
| Tempus Ai, INC | $19.45 | 2024 | |
| Myovant Sciences INC. | $18.59 | 2021 | |
| Beone Medicines USA, INC. | $18.40 | 2025 | Brukinsa |
| Lexicon Pharmaceuticals, INC. | $17.87 | 2019 | |
| Agios Pharmaceuticals, INC. | $17.72 | 2024 | Pyrukynd |
| Tg Therapeutics, INC. | $17.63 | 2021 | |
| Coherus Oncology, INC. | $17.41 | 2024 | |
| Curonix LLC | $17.28 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Immunocore Limited | $17.20 | 2025 | Kimmtrak |
| Aadi Bioscience, INC. | $16.40 | 2023 | Fyarro |
| Sun Pharmaceutical Industries INC. | $14.69 | 2023 | Yonsa, Odomzo |
| Caris Mpi, INC. | $14.04 | 2025 | Mi Cancer Seek |
| Napo Pharmaceuticals INC | $13.78 | 2025 | Gelclair Concentrated Oral Gel |
| Progenics Pharmaceuticals, INC. | $13.17 | 2024 | |
| Tactile Systems Technology INC | $12.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Woo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.